As per a report from Barron, a financial newspaper, shoemaker Skechers USA Inc is likely to report an earnings growth on par with Nike Inc over the next three years. According to analysts’ estimate, Skechers’ earnings-per-share is likely to rise… Read More ›
The deal will not only add to Pfizer’s EPS, but will also provide to stronger traction in the cancer drugs market. U.S. pharmaceutical giant Pfizer Inc stated it would acquire Array Biopharma Inc for $10.64 billion in cash. The potential… Read More ›
Harley Davidson’s earnings per share excluding items for the first quarter was 98 cents against the average analyst forecast of 65 cents per share. Harley Davidson has stuck to its full year forecast. On Tuesday, Harley-Davidson Inc reported that its… Read More ›
The Japanese healthcare firm wants to acquire Bristol-Myers Squibb’s over-the-counter drugs business. On Wednesday, France-headquartered Bristol-Myers Squibb Co has received an offer from Taisho Pharmaceutical Holdings Co Ltd, a Japanese healthcare firm, to acquire its over-the-counter drugs business UPSA for… Read More ›
Following John Flannery’s resignation from General Electric Co’s as its CEO, GE’s board has unanimously endorsed H. Lawrence Culp Jr as its CEO. General Electric Co’s CEO John Flannery has stepped down from his role in the company. The development… Read More ›
Brushing aside a report by monthly magazine Manager Magazin, Siemens said, details of its Visions 2020+ strategy are still being worked out. German engineering giant Siemens has trashed a report by Manager Magazin, a monthly magazine, which had said it… Read More ›
Tune in to the M&A channel to view the latest in the top prime time drama over Britain’s Sky. Topping Rupert Murdoch’s Twenty-First Century Fox’s bid for Britain’s Sky, Comcast Corp raised its offer to $32.5 billion. Previously, Fox had… Read More ›
Nestle’s stratgic alliance with Starbucks underscores the fact that it is not shy to partner with its peers midst fast changing market conditions. On Monday, in a strategic move aimed at creating a global coffee alliance, Swiss food giant Nestle… Read More ›
Johnson & Johnson expects an increase in demand for its cancer drugs. On Tuesday, Johnson & Johnson first quarterly report beat analysts’ estimate and raised its full-year sales forecast on the strength of a growing demand for its cancer drugs…. Read More ›
